Benefit-risk assessment of ropivacaine in the management of postoperative pain

Ropivacaine is a long-acting amide-type local anaesthetic, released for clinical use in 1996. In comparison with bupivacaine, ropivacaine is equally effective for subcutaneous infiltration, epidural and peripheral nerve block for surgery, obstetric procedures and postoperative analgesia. Nevertheles...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drug safety 2004-01, Vol.27 (14), p.1093-1114
Hauptverfasser:	ZINK, Wolfgang, GRAF, Bernhard M
Format:	Artikel
Sprache:	eng
Schlagworte:	Amides - administration & dosage Amides - adverse effects Amides - economics Amides - therapeutic use Analgesics Anesthetics, Local - administration & dosage Anesthetics, Local - adverse effects Anesthetics, Local - economics Anesthetics, Local - therapeutic use Biological and medical sciences Cost-Benefit Analysis Humans Medical sciences Neuropharmacology Pain, Postoperative - drug therapy Pharmacology. Drug treatments Risk Assessment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!